Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 309-665-4 | CAS number: 100683-96-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July 31, 2014
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Limit test:
- yes
Test material
- Reference substance name:
- Carbohydrates and Sugars, hexitols, anhydro
- EC Number:
- 309-665-4
- EC Name:
- Carbohydrates and Sugars, hexitols, anhydro
- Cas Number:
- 100683-96-3
- IUPAC Name:
- 2-(1,2-dihydroxyethyl)oxolane-3,4-diol; hexahydrofuro[3,2-b]furan-3,6-diol
- Test material form:
- other: liquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- -Details on animals
Number of animals: 5 animals/sex
Sex: Male and female, female rat were nulliparous and non-pregnant.
Age of animals at dosing: Young healthy adult rats
Body weight at treatment: 220 – 251 g
Acclimatization period: at least 6 days
- Diet: Animals received ssniff® SM R/M "Autoclavable complete diet for rats and mice – breeding and maintenance" produced by ssniff Spezialdiäten GmbH, D-59494 Soest Germany (Batch no.: 186 0298, expiry date: May 2014) ad libitum. The food is considered not to contain any contaminants that could reasonably be expected to affect the purpose or integrity of the study
- Water: Animals received tap water from the municipal supply, as for human consumption from a 500 ml bottle, ad libitum. Water quality control analysis is performed once every three months and microbiological assessment is performed monthly, by Veszprém County Institute of State Public Health and Medical Officer Service (ÁNTSZ, H-8201 Veszprém, József A.u.36., Hungary). The quality control results are retained in the archives at CiToxLAB Hungary Ltd.
- IN-LIFE DATES:
Experimental starting date: 14 May 2014
Experimental Completion date: 28 May 2014
Reception of Animals 08 May 2014
Treatment 14 May 2014 (Males no.: 6937, 6938, 6939, 6940, 6941), (Females no.: 6942, 6943, 6944, 6945, 6946)
Observation 14 – 28 May 2014, (Males no.: 6937, 6938, 6939, 6940, 6941) (Females no.: 6942, 6943, 6944, 6945, 6946)
Necropsy 28 May 2014 (Males no.: 6937, 6938, 6939, 6940, 6941) (Females no.: 6942, 6943, 6944, 6945, 6946)
- Husbandry
Animal health: Only healthy animals were used for the test. The veterinarian certified health status.
Housing: Individual caging
Cage type: Type II polypropylene/polycarbonate
Bedding: Lignocel Bedding for Laboratory Animals and Cotton Rolls (Supplement to Ani Pet Bedding) were available to animals during the study.
Lighting period: 12 hours daily, from 6.00 a.m. to 6.00 p.m.
Temperature: 21.4 – 25.0 °C
Relative humidity: 35 – 62 %
Ventilation: 15 – 20 air exchanges/hour
Enrichment:Rodents were housed with deep wood sawdust bedding to allow digging and other normal rodent activities.
The temperature and relative humidity were recorded twice daily during the study.
Administration / exposure
- Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- The test item was administered as a single dose without using any vehicle. The test item was placed onto a gauze pad.
The back of each animal was shaved (approximately 10 % area of the total body surface) approximately 24 hours prior to treatment. The test item was applied as a single dose as supplied to the shaved skin and remained in contact with the skin for the 24-hour exposure period. Sterile gauze pads were placed on the skin of rats to cover the test item. These gauze pads were kept in contact with the skin by a patch with adhesive hypoallergenic plaster. The entire trunk of the animal was then wrapped with semi occlusive plastic wrap for 24 hours.
At the end of the exposure period, the area of skin treated with the test item was washed with water of body temperature. - Duration of exposure:
- 24h
- Doses:
- The test item was not expected to be lethal at 2000 mg/kg bw. A limit test was therefore performed.
- No. of animals per sex per dose:
- 5
- Control animals:
- not required
- Details on study design:
- A single administration was performed by the dermal route and was followed by a fourteen-day observation period.
5 males (cages 1-5) and 5 females (cages 6-10) received 2000 mg/kg bw of test subtance.
Clinical observations were performed on the day of treatment at 1 and 5 hours after application of the test item and once each day for 14 days thereafter. Observations included the skin and fur, eyes and mucous membranes, the respiratory, circulatory, autonomic and central nervous system, somatomotor activity and behaviour pattern. Particular attention was directed to observation of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma.
Adverse skin reactions at the site of application were recorded daily following the removal of the dressing.
The body weights were recorded on Day 0 (before test item administration) and on Days 7 and 14 just before necropsy.
Macroscopic examination was performed on all animals. All animals were anaesthetised with Euthasol® 40 % (details in 3.1.3.) and exsanguinated. After examination of the external appearance, the cranial, thoracic and abdominal cavities were opened and the appearance of the tissues and organs was observed. All macroscopic changes were recorded.
The method used was not intended to allow the calculation of a precise LD50 value.
The test item was ranked into categories of Globally Harmonized Classification System (GHS (rev 5.) 2013). - Statistics:
- no
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- The test item did not cause mortality at the dose level of 2000 mg/kg bw.
- Clinical signs:
- No clinical signs were observed after the treatment with the test item during the 14 day observation period.
- Body weight:
- There were no effects on bodyweight in any animal during the study.
- Gross pathology:
- No macroscopic findings were observed.
- Other findings:
- No dermal signs were observed after treatment with the test item during the 14 day observation period.
Any other information on results incl. tables
CLINICAL OBSERVATIONS
SEX: MALE
Cage No. |
Animal No. |
observations |
Observation days |
|
|
|
|
|
|
|
|
|
Frequency |
||||||
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
|||||
1h |
5h |
||||||||||||||||||
1 |
6937 |
Symptom free |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
16/16 |
2 |
6938 |
Symptom free |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
16/16 |
3 |
6939 |
Symptom free |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
16/16 |
4 |
6940 |
Symptom free |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
16/16 |
5 |
6941 |
Symptom free |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
16/16 |
SEX: FEMALE
Cage No. |
Animal No. |
observations |
Observation days |
|
|
|
|
|
|
|
|
|
Frequency |
||||||
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
|||||
1h |
5h |
||||||||||||||||||
1 |
6942 |
Symptom free |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
16/16 |
2 |
6943 |
Symptom free |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
16/16 |
3 |
6944 |
Symptom free |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
16/16 |
4 |
6945 |
Symptom free |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
16/16 |
5 |
6946 |
Symptom free |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
16/16 |
Treatment day = Day 0
+ = present
h = hour (s)
Frequency of observation = number of occurence of observation / total number of observations
BODY WEIGHT DATA
SEX: MALE
Cage No. |
Animal No. |
Body weight (g) Days |
Body weight gain (g) Days |
||||
0 |
7 |
14 |
0-7 |
7-14 |
0-14 |
||
1 |
6937 |
233 |
283 |
333 |
50 |
50 |
100 |
2 |
6938 |
231 |
293 |
331 |
62 |
38 |
100 |
3 |
6939 |
228 |
270 |
315 |
42 |
45 |
87 |
4 |
6940 |
220 |
267 |
318 |
47 |
51 |
98 |
5 |
6941 |
238 |
292 |
332 |
54 |
40 |
94 |
Mean |
230.0 |
281.0 |
325.8 |
51.0 |
44.8 |
95.8 |
|
Standard deviation |
6.7 |
12.1 |
8.6 |
7.5 |
5.8 |
5.5 |
SEX: FEMALE
Cage No. |
Animal No. |
Body weight (g) Days |
Body weight gain (g) Days |
||||
0 |
7 |
14 |
0-7 |
7-14 |
0-14 |
||
1 |
6942 |
246 |
249 |
268 |
3 |
19 |
22 |
2 |
6943 |
242 |
253 |
254 |
11 |
1 |
12 |
3 |
6944 |
234 |
246 |
250 |
12 |
4 |
16 |
4 |
6945 |
251 |
252 |
264 |
1 |
12 |
13 |
5 |
6946 |
231 |
240 |
252 |
9 |
12 |
21 |
Mean |
240.8 |
248.0 |
257.6 |
7.2 |
9.6 |
16.8 |
|
Standard deviation |
8.3 |
5.2 |
7.9 |
4.9 |
7.2 |
4.5 |
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute dermal median lethal dose (LD50) of the test item Carbohydrates and Sugars, hexitols, anhydro - LAB 4623 was found to be greater than 2000 mg/kg body weight in male and female CRL:(WI) rats.
According to the Globally Harmonized System of Classification and Labelling of Chemicals and to CLP-Regulation (EC) No. 1272/2008, Carbohydrates and Sugars, hexitols, anhydro - LAB 4623 is ranked respectively as "Category 5" or "Unclassified" for acute dermal exposure. - Executive summary:
An acute dermal toxicity study was performed with test item Carbohydrates and Sugars, hexitols, anhydro - LAB 4623 in CRL:(WI) rats, in compliance with OECD Guideline No.: 402.
A limit test was carried out at 2000 mg/kg body weight (bw) in both sexes (5 rats/sex). The test item was applied as supplied as a single dermal 24-hour exposure followed by a 14-day observation period.
Clinical observations were performed on all animals at 1 and 5 hours after dosing and daily for 14 days thereafter. Body weight was measured prior to dosing on Day 0 and on Days 7 and 14. Gross macroscopic examination was performed on all animals at the end of the 2-week observation period (Day 14).
Test item did not cause mortality at dose level of 2000 mg/kg bw. No clinical signs were observed after the treatment with the test item during the 14-day observation period. No dermal signs were observed after treatment with the test item during the 14-day observation period. There were no effects on bodyweight in any animal during the study. No macroscopic findings were observed.
The acute dermal median lethal dose (LD50) of the test item Carbohydrates and Sugars, hexitols, anhydro - LAB 4623 was found to be greater than 2000 mg/kg body weight in male and female CRL:(WI) rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.